COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Socit dAndrologie de langue Franaise SALF)

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) metamorphosed our medical practice In early June 2020, more than 6,400,000 COVID-19 (coronavirus-19 disease) cases were diagnosed across the world and more than 380,000 deaths were linked to COVID-19 Many medical symptoms of COVID-19 were reported We will focus, here, on potential impacts of COVID-19 on men�s andrological health Our society (French-speaking society of andrology, SALF) also emitted some recommendations in the andrological management of men infected by SARS-CoV-2 First, considering the fever and the potential presence of SARS-CoV2 in semen, SALF recommends waiting for 3?months (duration of one spermatogenesis cycle and epididymal transit) before re-starting ART in the case of men diagnosed COVID-19 positive Whatever the nature of testosterone and COVID-19 relationships, we recommend an andrological examination, sperm parameters, and hormonal evaluation at the time of the COVID-19 is diagnosed, and several months later Furthermore, we are concerned by the potential morbid-mortality of the COVID-19, which mainly affects men This �andrological bias�, if proven, must be reduced by specific andrological diagnosis, therapeutic and prophylactic measures Research in this direction must be substantiated and financially supported over the next few months (years)